abstract |
(57) Summary The present invention relates to compounds of formula (I) and pharmaceutically acceptable salts thereof. The compounds of formula (I) show activity as serotonin, norepinephrine, and dopamine reuptake inhibitors and can be used in the treatment of the central nervous system and other disorders. [Chemical 1] |